Evidence map›Paper›PMID 37128805›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2023

Percutaneous paravalvular leak closure after transcatheter aortic valve implantation: the international PLUGinTAVI Registry.

Eduardo Flores-Umanzor, Jason Nogic, Pedro Cepas-Guillén, Sebastian Hascoet, Piotr Pysz, Jose Antonio Baz, Ignacio Cruz-González, Ignacio J Amat-Santos, Pablo Antúnez-Muiños, Jose Carlos González and 13 more

Open access · greenAbstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Pathophysiology, diagnosis, and management of hemolysis in patients with prosthetic valve related paravalvular leaks.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2026
    Review
  5. Transcatheter Paravalvular Leak Closure: A Step-by-Step Guide.Journal of cardiovascular development and disease · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 4 countries.

Eduardo Flores-UmanzorPeter Munk Cardiac Centre, Toronto General Hospital, University Health Network (UHN), Toronto, ON, Canada.
Jason NogicDepartment of Cardiology, Royal Papworth Hospital, Cambridge, UK.
Pedro Cepas-GuillénHospital Clinic de Barcelona, Institut Clinic Cardiovascular, IDIBAPS, Barcelona, Spain.
Sebastian HascoetDepartment of Congenital Heart Diseases, Marie Lannelongue Hospital, M3C Network, INSERM UMR-S 999, Paris-Saclay University, Plessis-Robinson, Paris, France.
Piotr PyszMedical University of Silesia, Katowice, Poland.
Jose Antonio BazCardiovascular Research Group, Department of Cardiology, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IIS Galicia Sur), Servizo Galego de Saude, University of Vigo, Vigo, Spain.
Ignacio Cruz-GonzálezHospital Universitario de Salamanca, IBSAL, CIBER-CV, Salamanca, Spain.
Ignacio J Amat-SantosHospital Universitario de Valladolid, Valladolid, Spain.
Pablo Antúnez-MuiñosHospital Universitario de Salamanca, IBSAL, CIBER-CV, Salamanca, Spain.
Jose Carlos GonzálezHospital Universitario de Valladolid, Valladolid, Spain.
Valeriano Ruíz-QuevedoHospital Universitario de Navarra, Navarra, Spain.
Rodrigo Estevez-LoureiroCardiovascular Research Group, Department of Cardiology, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IIS Galicia Sur), Servizo Galego de Saude, University of Vigo, Vigo, Spain.
Benoit GerardinDepartment of Congenital Heart Diseases, Marie Lannelongue Hospital, M3C Network, INSERM UMR-S 999, Paris-Saclay University, Plessis-Robinson, Paris, France.
Xavier MillanHospital Santa Creu i Sant Pau, Barcelona, Spain.
Marcel Santaló-CorcoyMontreal Heart Institute, Montreal, QC, Canada.
Ander RegueiroHospital Clinic de Barcelona, Institut Clinic Cardiovascular, IDIBAPS, Barcelona, Spain.
Réda IbrahimMontreal Heart Institute, Montreal, QC, Canada.
Dabit ArzamendiHospital Universitario de Valladolid, Valladolid, Spain.
Eustaquio Maria OnoratoCardiologia Universitaria, Ospedale Galeazzi - Sant'Ambrogio, IRCCS, Milan, Italy.
Josep Rodés-CabauQuebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
Eric HorlickPeter Munk Cardiac Centre, Toronto General Hospital, University Health Network (UHN), Toronto, ON, Canada.
Patrick A CalvertDepartment of Cardiology, Royal Papworth Hospital, Cambridge, UK.
Xavier FreixaHospital Clinic de Barcelona, Institut Clinic Cardiovascular, IDIBAPS, Barcelona, Spain.
Hospital Clínico Universitario de Valladolid · ESHospital Clínic de Barcelona · ESMontreal Heart Institute · CAPapworth Hospital · GBUniversity Health Network · CAConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESGalicia Sur Biomedical Foundation · ESHospital de Sant Pau · ESMedical University of Silesia · PLUniversidad de Navarra · ESUniversidade de Vigo · ESUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData regarding the safety and long-term effectiveness of percutaneous closure of paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) are scarce.

aimsThis study aims to present a large multicentre international experience of percutaneous post-TAVI PVL closure.

methodsAll patients who underwent percutaneous post-TAVI PVL closure in 14 hospitals across Europe and North America between January 2018 and October 2022 were included.

resultsOverall, 45 patients (64% male) were enrolled. The median age was 80 years (75-84). Among them, 67% and 33% had self-expanding and balloon-expandable valve implantations, respectively. Baseline post-TAVI PVL was severe in 67% of cases and moderate in the rest. The time from index TAVI to PVL closure procedure was 16.1 (8.7-34.8) months. Most patients were in NYHA Class III and IV (73%) before the procedure, and 40% had referred hospitalisations for heart failure between TAVI and the PVL closure procedure. Successful PVL closure was achieved in 94%, reducing regurgitation to ≤mild in 91% and moderate in the rest. The Amplatzer Valvular Plug III was the most frequently used device (27 cases), followed by the Amplatzer Valvular Plug 4. The incidence of severe adverse events was 11%. None of the patients died during the index hospitalisation. During long-term follow-up (21.7±16.2 months), the all-cause mortality rate was 14%, and patients presented improvement in functional status and a significant reduction in the rate of hospitalisation for heart failure (from 40% to 6%).

conclusionsPercutaneous PVL closure is a feasible and safe option for treating post-TAVI leaks. Successful PVL reduction to mild or less could be associated with acute and long-lasting improvements in clinical outcomes.

Indexed as

Aortic Valve StenosisHeart FailureHeart Valve ProsthesisHeart Valve Prosthesis ImplantationTranscatheter Aortic Valve ReplacementAged, 80 and overAortic ValveFemaleHumansMaleRegistriesTreatment Outcome

Identifiers

PMID37128805
PMCPMC10397666
OpenAlexW4367668437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.